ABC | Volume 111, Nº3, Setembro 2018

Diretrizes Diretriz Brasileira de Insuficiência Cardíaca Crônica e Aguda Arq Bras Cardiol. 2018; 111(3):436-539 682. DharmarajanK,HsiehAF,KulkarniVT,LinZ,RossJS,HorwitzLI,etal.Trajectories of risk after hospitalization for heart failure, acute myocardial infarction, or pneumonia:retrospectivecohortstudy.BMJ. 2015Feb5;350:h411. 683. Gheorghiade M, Filippatos G, De Luca L, Burnett J. Congestion in acute heart failure syndromes: an essential target of evaluation and treatment. Am J Med. 2006;119(12 Suppl 1):S3-S10. 684. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, et al. Transition fromchronic compensated to acute decompensated heart failure: pathophysiological insights obtained fromcontinuous monitoring of intracardiac pressures. Circulation. 2008;118(14):1433-41. 685. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, et al; CHAMPION Trial Study Group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet. 2011;377(9766):658-66. 686. Lee DS, Stukel TA, Austin PC, Alter DA, Schull MJ, You JJ, et al. Improved outcomes with early collaborative care of ambulatory heart failure patients discharged from the emergency department. Circulation. 2010;122(18):1806-14. 687. Blood AJ, Fraiche AM, Eapen ZJ. Is an admission for decompensated heart failure inevitable? Prog Cardiovasc Dis. 2017;60(2):171-7. 688. Dolansky MA, Capone L, Leister E, Boxer RS. Targeting heart failure rehospitalizations in a skilled nursing facility: a case report. Heart Lung. 2016;45(5):392-6. 689. Saito M, Negishi K, Marwick TH. Meta-analysis of risks for short-term readmissioninpatientswithheartfailure.AmJCardiol.2016;117(4):626-32. 690. KansagaraD, Englander H, Salanitro A, KagenD, Theobald C, FreemanM, et al. Risk predictionmodels for hospital readmission: a systematic review. JAMA. 2011;306(15):1688-98. 691. Attaallah S, Klymko K, Hopp FP. Self-care among older adults with heart failure. Gerontol Geriatr Med. 2016 Dec 21;2:2333721416684013. 692. Rice H, Say R, Betihavas V. The effect of nurse-led education on hospitalisation, readmission, quality of life and cost in adults with heart failure:a systematic review. Patient Educ Couns. 2018;101(3):363-374. 693. WanTT,TerryA,CobbE,McKeeB,TregermanR,BarbaroSD.Strategiestomodify the risk of heart failure readmission: a systematic review and meta-analysis. HealthServResManagEpidemiol.2017Apr18;4:2333392817701050. 694. Soundarraj D, Singh V, Satija V, Thakur RK. Containing the cost of heart failure management: a focus on reducing readmissions. Heart Fail Clin. 2017;13(1):21-8. 695. Hernandez AF, Greiner MA, Fonarow GC, Hammill BG, Heidenreich PA, Yancy CW, et al. Relationship between early physician follow-up and 30-day readmission among Medicare beneficiaries hospitalized for heart failure. JAMA. 2010;303(17):1716-22. 696. Duflos CM, Solecki K, Papinaud L, Georgescu V, Roubille F, Mercier G. The Intensity of primary care for heart failure patients: a determinant of readmissions? The CarPaths Study: A French region-wide analysis. PLoS One. 2016;11(10):e0163268. 697. Di Palo KE, Patel K, Assafin M, Piña IL. Implementation of a Patient navigator program to reduce 30-day heart failure readmission rate. Prog Cardiovasc Dis. 2017;60(2):259-66. 698. Huntley AL, Johnson R, King A, Morris RW, Purdy S. Does case management forpatientswithheart failurebased inthecommunityreduce unplanned hospital admissions? A systematic review and meta-analysis. BMJ Open. 2016;6(5):e010933. 699. Monza K, Harris D, Shaw C. The role of the nurse navigator in the management of the heart failure patient. Crit Care Nurs Clin North Am. 2015;27(4):537-49. 700. Luttik ML, Jaarsma T, van Geel PP, Brons M, Hillege HL, Hoes AW, et al. Long-term follow-up in optimally treated and stable heart failure patients: primary care vs. heart failure clinic. Results of the COACH-2 study. Eur J Heart Fail. 2014;16(11):1241-8. 701. KillipT3 rd ,KimballJT.Treatmentofmyocardialinfarctioninacoronarycareunit. Atwoyearexperiencewith250patients.AmJCardiol.1967;20(4):457-64. 702. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al; ABP-SHOCK II Trial Investigators. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012;367(14):1287-96. 703. El-Banayosy A, CobaughD, Zittermann A, Kitzner L, Arusoglu L, Morshuis M, et al. A multidisciplinary network to save the lives of severe, persistent cardiogenic shock patients. Ann Thorac Surg. 2005;80(2):543-7. 704. Schmidt M, Burrell A, Roberts L, Bailey M, Sheldrake J, Rycus PT, et al. Predicting survival after ECMO for refractory cardiogenic shock: the survival after veno-arterial-ECMO (SAVE)-score. Eur Heart J. 2015;36(33):2246-56. 705. Doll JA, Ohman EM, Patel MR, Milano CA, Rogers JG, Wohns DH, et al. A team-based approach to patients in cardiogenic shock. Catheter Cardiovasc Interv. 2016;88(3):424-33. 706. Johnston L, Oldenburg G. Simulation for neonatal extracorporeal membrane oxygenation teams. Semin Perinatol. 2016;40(7):421-9. 707. LansdowneW,MachinD,GrantDJ.Developmentoftheorpheusperfusion simulator for use in high-fidelity extracorporeal membrane oxygenation simulation. J Extra Corpor Technol. 2012;44(4):250-5. 708. Montero S, Combes A, Schmidt M. The extracorporeal membrane oxygenation (ECMO) high-fidelity simulator: the best complementary tool to learn the technique. J Thorac Dis. 2017;9(11):4273-6. 709. Al Disi M, Alsalemi A, Alhomsi Y, Bensaali F, Amira A, Alinier G. Revolutionizing ECMO simulation with affordable yet high-Fidelity technology. Am J Emerg Med. 2018;36(7):1310-2. 710. Pu ś lecki M, Ligowski M, Kiel M, D ą browski M, Stefaniak S, Maciejewski A, et al. ECMO therapy simulator for extracorporeal life support. Am J Emerg Med. 2018;36(3):506-8. 711. Na SJ, Chung CR, Jeon K, Park CM, Suh GY, Ahn JH, et al. Association Between Presence of a Cardiac Intensivist and Mortality in an Adult Cardiac Care Unit. J Am Coll Cardiol. 2016;68(24):2637-48. 712. NaSJ,ParkTK,LeeGY,ChoYH,ChungCR, JeonK,etal. Impactofacardiac intensivist on mortality in patients with cardiogenic shock. Int J Cardiol. 2017 Oct 1;244:220-5. 713. Katz JN, Minder M, Olenchock B, Price S, Goldfarb M, Washam JB, et al. The Genesis, Maturation, and Future of Critical Care Cardiology. J AmColl Cardiol. 2016;68(1):67-79. 714. Pronovost PJ, Angus DC, Dorman T, Robinson KA, Dremsizov TT, Young TL. Physician staffing patterns and clinical outcomes in critically ill patients: a systematic review. JAMA. 2002;288(17):2151-62. 715. Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, et al; ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119-77. 716. Rossello X, Vila M, Rivas-Lasarte M, Ferrero-Gregori A, Sans-Roselló J, Duran-Cambra A, et al. Impact of pulmonary artery catheter use on short- and long-term mortality in patients with cardiogenic shock. Cardiology. 2017;136(1):61-9. 717. Yamazaki Y, Oba K, Matsui Y, Morimoto Y. Vasoactive-inotropic score as a predictor of morbidity and mortality in adults after cardiac surgery with cardiopulmonary bypass. J Anesth. 2018;32(2):167-73. 718. Gaies MG, Jeffries HE, Niebler RA, Pasquali SK, Donohue JE, Yu S, et al. Vasoactive-inotropic score is associated with outcome after infant cardiac surgery: an analysis from the Pediatric Cardiac Critical Care Consortium and Virtual PICU System Registries. Pediatr Crit Care Med. 2014;15(6):529-37. 537